U.S. drugmaker Merck is nearing a deal worth about $10 billion to buy Verona Pharma, a company focused on therapies for lung ...

The multi-time MMA champion said he lost 50 pounds in a 45-day period as he fought for his life in a Wisconsin hospital.

Merck will buy UK-based Verona Pharma for about $10 billion, the companies said on Wednesday, strengthening the U.S. firm's ...

Corticosteroids are commonly prescribed to alleviate cancer-related symptoms in patients with non-small cell lung cancer, ...

Lung cancer, the second-most common cancer in the U.S., is often associated with smoking — but even those who have never had ...

DURING SCREENING SEASON, which runs from March to December, LUCAS sets off on Mondays from the cancer institute in Morgantown ...

Australia has launched its first lung cancer screening program, which targets current and recent smokers with biennial ...

The primary measure of ILD progression was a decline in forced vital capacity (FVC) of 5% or more between annual visits.

Merck is looking to strengthen its respiratory treatments as part of efforts to reduce dependence on its blockbuster cancer treatment.

An international study found that air pollution leads to more cancer-related genetic changes than secondhand smoke.

Merck said it will buy Verona Pharma for $10 billion to bolster its lung-disease business and help replace the expected loss ...